Financial reports
10-Q
2024 Q3
Quarterly report
25 Mar 24
NT 10-Q
Notice of late quarterly filing
18 Mar 24
10-Q
2024 Q2
Quarterly report
15 Dec 23
10-Q
2024 Q1
Quarterly report
13 Sep 23
10-K
2023 FY
Annual report
27 Jul 23
10-Q
2023 Q3
Quarterly report
15 Mar 23
10-Q
2022 Q2
Quarterly report
12 Dec 22
10-Q
2022 Q1
Quarterly report
13 Sep 22
10-K
2022 FY
Annual report
19 Jul 22
10-Q
2022 Q3
Quarterly report
15 Mar 22
Current reports
8-K
Financial Statements and Exhibits
13 May 24
8-K/A
Entry into a Material Definitive Agreement
10 May 24
8-K
Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
9 May 24
8-K
Changes in Registrant's Certifying Accountant
9 May 24
8-K
Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program
7 May 24
8-K
Submission of Matters to a Vote of Security Holders
1 May 24
8-K
Entry into a Material Definitive Agreement
30 Apr 24
8-K
Entry into a Material Definitive Agreement
29 Mar 24
8-K
Entry into a Material Definitive Agreement
22 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
7 Mar 24
Registration and prospectus
424B5
Prospectus supplement for primary offering
10 May 24
424B5
Prospectus supplement for primary offering
7 May 24
424B5
Prospectus supplement for primary offering
8 Sep 23
S-3
Shelf registration
2 Aug 23
S-8
Registration of securities for employees
13 Jul 21
424B4
Prospectus supplement with pricing info
15 Jun 21
S-1/A
IPO registration (amended)
11 Jun 21
8-A12B
Registration of securities on exchange
11 Jun 21
FWP
Free writing prospectus
7 Jun 21
S-1/A
IPO registration (amended)
7 Jun 21
Proxies
PRE 14A
Preliminary proxy
10 May 24
DEFA14A
Additional proxy soliciting materials
1 May 24
DEF 14A
Definitive proxy
25 Mar 24
PRE 14A
Preliminary proxy
13 Mar 24
DEFA14A
Additional proxy soliciting materials
1 Sep 23
DEF 14A
Definitive proxy
24 Aug 23
PRE 14A
Preliminary proxy
10 Aug 23
DEF 14A
Definitive proxy
31 Mar 23
Other
EFFECT
Notice of effectiveness
11 Aug 23
CORRESP
Correspondence with SEC
8 Aug 23
UPLOAD
Letter from SEC
8 Aug 23
EFFECT
Notice of effectiveness
15 Jun 21
CORRESP
Correspondence with SEC
15 Jun 21
CERT
Certification of approval for exchange listing
14 Jun 21
CORRESP
Correspondence with SEC
14 Jun 21
CORRESP
Correspondence with SEC
10 Jun 21
CORRESP
Correspondence with SEC
10 Jun 21
CORRESP
Correspondence with SEC
10 Jun 21
Ownership
4
MILTON C AULT III
23 Apr 24
4
MILTON C AULT III
3 Apr 24
4
MILTON C AULT III
1 Apr 24
4
MILTON C AULT III
28 Mar 24
SC 13D/A
AULT MILTON C III
2 Feb 24
4
MILTON C AULT III
2 Feb 24
SC 13D/A
AULT MILTON C III
25 Jan 24
4
MILTON C AULT III
25 Jan 24
4
MILTON C AULT III
9 Jan 24
4
MILTON C AULT III
27 Dec 23